Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach.
Villalvazo P, Marzal-Alfaro B, García-Alfonso P, Revuelta-Herrero JL, Thomas F, López-Tarruella S, García-González X, Calvo A, Yakoubi M, Salvador-Martín S, López-López F, Aguilar I, Sanjurjo-Sáez M, Martín M, López-Fernández LA. Villalvazo P, et al. Among authors: revuelta herrero jl. J Pers Med. 2021 Aug 13;11(8):792. doi: 10.3390/jpm11080792. J Pers Med. 2021. PMID: 34442436 Free PMC article.
Pazopanib-Associated Transient Ischemic Attack.
Revuelta-Herrero JL, Escudero-Vilaplana V, Álvarez-Álvarez R, Sanjurjo-Sáez M. Revuelta-Herrero JL, et al. Am J Ther. 2018 May/Jun;25(3):e393-e394. doi: 10.1097/MJT.0000000000000710. Am J Ther. 2018. PMID: 29424756 No abstract available.
Risks and medication errors analysis to evaluate the impact of a chemotherapy compounding workflow management system on cancer patients' safety.
Marzal-Alfaro M, Rodriguez-Gonzalez CG, Escudero-Vilaplana V, Revuelta-Herrero JL, González-Haba E, Ibáñez-Garcia S, Iglesias-Peinado I, Herranz-Alonso A, Sanjurjo Saez M. Marzal-Alfaro M, et al. Health Informatics J. 2020 Sep;26(3):1995-2010. doi: 10.1177/1460458219895434. Epub 2020 Jan 8. Health Informatics J. 2020. PMID: 31912756 Free article.
Tocilizumab as salvage treatment of refractory pulmonary acute graft-versus-host disease.
Melgarejo-Ortuño A, Escudero-Vilaplana V, Revuelta-Herrero JL, Bailen R, Collado-Borrell R, Gomez-Centurión I, Oarbeascoa G, Kwon M, Herranz-Alonso A, Diez-Martin JL, Sanjurjo-Saez M. Melgarejo-Ortuño A, et al. J Oncol Pharm Pract. 2021 Apr;27(3):751-755. doi: 10.1177/1078155220948934. Epub 2020 Aug 12. J Oncol Pharm Pract. 2021. PMID: 32787560
Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice.
Escudero-Vilaplana V, Collado-Borrell R, Del Monte-Millán M, Hoyo-Muñoz A, Gómez Martínez-Sagrera P, Revuelta-Herrero JL, Marzal-Alfaro B, Gonzalez-Haba E, López-Tarruella Cobo S, Jerez Gilarranz Y, Herranz A, Sanjurjo M, Martin M. Escudero-Vilaplana V, et al. Support Care Cancer. 2021 Aug;29(8):4673-4681. doi: 10.1007/s00520-021-06016-z. Epub 2021 Jan 28. Support Care Cancer. 2021. PMID: 33506273
20 results